Biotech Next Gen 2021 has ended
Back To Schedule
Wednesday, June 23 • 10:50am - 11:05am
Manufacturing of new modalities: New opportunities come with new challenges

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.
A shift toward precision and personalized medicine is a growth driver in the pharmaceutical industry. Biologics and advanced modalities ranging from antibody-drug conjugates and mRNA-based drugs to cell and gene therapies contribute to this growth. However, these new modalities bring a new set of challenges for innovators striving to manufacture at sufficient scale to simultaneously meet market demand, high-quality standards, expected production cost and an acceptable ROI. Dr. Mahdavi’s talk will review key growth areas, innovative technologies and future strategies designed to increase the efficiency and scalability of these advanced therapeutics.

avatar for Behzad Mahdavi, Ph.D.

Behzad Mahdavi, Ph.D.

Vice President, Open Innovation, Biologics, Cell & Gene Therapy, Catalent
With over 20 years’ experience in developing and implementing impactful growth strategies in the biopharmaceutical industries, Dr. Mahdavi joined Catalent in 2020 after a 13-year career at Lonza, where he held the role of Vice President Strategic Innovation & Alliances, and... Read More →

Wednesday June 23, 2021 10:50am - 11:05am EDT